Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018–2020

Qianhui Wua Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, ChinaView further author information

Mengcen Qiana Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, China;b Key Laboratory of Health Technology Assessment, Ministry of Health, Fudan University, Shanghai, ChinaView further author information

Sarah Welbyc GSK, Wavre, BelgiumView further author information

Adrienne Guignardc GSK, Wavre, BelgiumView further author information

Dominique Rosillonc GSK, Wavre, BelgiumView further author information

Kusuma Gopalad GSK, Bangalore, IndiaView further author information

Yuan Xue GSK, Wuhan, ChinaView further author information

Keruo Liuf GSK, Shanghai, ChinaView further author information

Yunkun Hef GSK, Shanghai, ChinaView further author information

Ning Jiangf GSK, Shanghai, ChinaView further author information

Qin Tang Shunde District Center for Disease Control and Prevention, Guangdong, ChinaView further author information

Jiamin Xieg Shunde District Center for Disease Control and Prevention, Guangdong, ChinaView further author information

Taoying Zhuh Wuhou District Center for Disease Control and Prevention, Sichuan, ChinaView further author information

Qizhang Wangi Pudong New Area Center for Disease Control and Prevention, Shanghai, ChinaView further author information

Yingzi Panj Wujin District Center for Disease Control and Prevention, Jiangsu, ChinaView further author information

Ruikun Zengk Longgang District Center for Disease Control and Prevention, Guangdong, ChinaView further author information

Jie Yangl Luohu District Center for Disease Control and Prevention, Guangdong, ChinaView further author information

Xiaoqian Zhaom Taocheng District Center for Disease Control and Prevention, Hebei, ChinaView further author information

Man Zhoun Xicheng District Center for Disease Control and Prevention, Beijing, ChinaView further author information

Adoración Navarro-Tornéc GSK, Wavre, BelgiumView further author information

Hongjie Yua Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, China;o Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China;p Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, ChinaCorrespondence[email protected]